GLP1 Weight Loss Drug Costs Drive Higher CoPays Across Insurance Plans American Graphics Signs Expands Fleet Graphics Installation Network to All 50 States HighYield Savings Rates Reach 41 APY as of May 23 2026 What Savers Should Know Emirates NBD Announces Open Offer for 26 Stake in RBL Bank Starting June 1 Powell Vows No Shadow Chair Role but Historic Fed Meeting with Former Chair Looms Needham Analysts Lower Workday WDAY Price Target Amid Market Caution Regency Centers Corporation 625 Series A Cumulative Redeemable Preferred Stock REGCP Q1 2026 Earnings Strong EPS Beat Signals Steady Preferred Dividend Coverage BLDR Q1 2026 Earnings EPS Misses Estimates by 284 Stock Edges Higher TEM Q1 2026 Earnings Narrower Loss Surprises Analysts but Stock Slides Smurfit WestRock Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges BTSGU Q1 2026 Earnings EPS Surpasses Estimates by 23 Stock Flat amid Strong Operational Performance PERF Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response Silexion Therapeutics Warrants SLXNW Hold Steady at 002 Amid Thin Trading Maui Land Pineapple MLP Edges Higher as Support Holds Near 162 Telecom Argentina TEO Holds Steady Near 1186 as Market Awaits Catalyst AEye Inc Warrant LIDRW Surges 10 but Holds at Key Support Analysis of Recent Activity Elemental Royalty ELE Slips to 1669 as Bearish Momentum Persists Lowes Signals Caution as Consumer Spending Patterns Shift ROP Q1 2026 Earnings EPS Beats Estimates Revenue Not Disclosed Ambow Education AMBO Bounces Back Stock Rises 38 as Price Approaches Resistance First BanCorp Q1 2026 Earnings EPS Surpasses Estimates Amid Stable Operations American Express Q1 2026 Earnings EPS Surpasses Estimates at 428 Stock Edges Higher Contineum Therapeutics Inc CTNM Q1 2026 Earnings Narrower Loss Beats Expectations XTNT Q1 2026 Earnings EPS Misses Estimates Despite Stock Gain SCI Q1 2026 Earnings EPS Misses Estimates by 44 Shares Edge Higher MFG Q1 2026 Earnings Strong EPS Beat of 284 as Net Interest Income Rises Yet Stock Edges Lower GLUE Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline